Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Corcept Shareholders Between October 31, 2024 and December 30, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
-
The lawsuit alleges that defendants failed to disclose that the FDA raised concerns about the adequacy of evidence supporting relacorilant’s NDA.
-
Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
-
Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
-
Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
-
Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
-
Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
-
Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
-
Corcept Therapeutics Shareholders - Contact Bernstein Liebhard For More Information Regarding Shareholder Investigation
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Corcept (CORT) To Contact Him Directly To Discuss Their Options If you purchased or...